The Micro-Elimination Approach to Eliminating Hepatitis C: Strategic and Operational Considerations

Kelly Safreed‐Harmon(Barcelona Institute for Global Health), Mark Thursz(Imperial College London), John Dillon(University of Dundee), Manal H. El‐Sayed(Ain Shams University), Ahmed M. Elsharkawy, Angelos Hatzakis(National and Kapodistrian University of Athens), Michel Jadoul(Cliniques Universitaires Saint-Luc), Tullio Prestileo(Azienda di Rilievo Nazionale ed Alta Specializzazione), Homie Razavi(Center for Disease Analysis), Jürgen K. Rockstroh(University of Bonn), Stefan Z. Wiktor(University of Washington), Massimo Colombo(IRCCS Humanitas Research Hospital), Jeffrey V. Lazarus(Barcelona Institute for Global Health)
Seminars in Liver Disease
July 9, 2018
Cited by 257Open Access
Full Text

Abstract

The introduction of efficacious new hepatitis C virus (HCV) treatments galvanized the World Health Organization to define ambitious targets for eliminating HCV as a public health threat by 2030. Formidable obstacles to reaching this goal can best be overcome through a micro-elimination approach, which entails pursuing elimination goals in discrete populations through multi-stakeholder initiatives that tailor interventions to the needs of these populations. Micro-elimination is less daunting, less complex, and less costly than full-scale, country-level initiatives to eliminate HCV, and it can build momentum by producing small victories that inspire more ambitious efforts. The micro-elimination approach encourages stakeholders who are most knowledgeable about specific populations to engage with each other and also promotes the uptake of new models of care. Examples of micro-elimination target populations include medical patients, people who inject drugs, migrants, and prisoners, although candidate populations can be expected to vary greatly in different countries and subnational areas.


Related Papers

No related papers found

Powered by citation graph analysis